Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

The genetic basis of primary aldosteronism.

Funder JW.

Curr Hypertens Rep. 2012 Apr;14(2):120-4. doi: 10.1007/s11906-012-0255-x. Review.

PMID:
22359160
[PubMed - indexed for MEDLINE]
2.

KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.

Mulatero P, Tauber P, Zennaro MC, Monticone S, Lang K, Beuschlein F, Fischer E, Tizzani D, Pallauf A, Viola A, Amar L, Williams TA, Strom TM, Graf E, Bandulik S, Penton D, Plouin PF, Warth R, Allolio B, Jeunemaitre X, Veglio F, Reincke M.

Hypertension. 2012 Feb;59(2):235-40. doi: 10.1161/HYPERTENSIONAHA.111.183996. Epub 2011 Dec 27.

PMID:
22203740
[PubMed - indexed for MEDLINE]
Free Article
3.

Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.

Murthy M, Xu S, Massimo G, Wolley M, Gordon RD, Stowasser M, O'Shaughnessy KM.

Hypertension. 2014 Apr;63(4):783-9. doi: 10.1161/HYPERTENSIONAHA.113.02234. Epub 2014 Jan 13.

PMID:
24420545
[PubMed - indexed for MEDLINE]
4.

Primary aldosteronism and potassium channel mutations.

Stowasser M.

Curr Opin Endocrinol Diabetes Obes. 2013 Jun;20(3):170-9. doi: 10.1097/MED.0b013e32835ef2fd. Review.

PMID:
23426162
[PubMed - indexed for MEDLINE]
5.

Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas.

Azizan EA, Murthy M, Stowasser M, Gordon R, Kowalski B, Xu S, Brown MJ, O'Shaughnessy KM.

Hypertension. 2012 Mar;59(3):587-91. doi: 10.1161/HYPERTENSIONAHA.111.186239. Epub 2012 Jan 17.

PMID:
22252394
[PubMed - indexed for MEDLINE]
Free Article
6.

Role of KCNJ5 in familial and sporadic primary aldosteronism.

Mulatero P, Monticone S, Rainey WE, Veglio F, Williams TA.

Nat Rev Endocrinol. 2013 Feb;9(2):104-12. doi: 10.1038/nrendo.2012.230. Epub 2012 Dec 11. Review.

PMID:
23229280
[PubMed - indexed for MEDLINE]
7.

Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.

Boulkroun S, Beuschlein F, Rossi GP, Golib-Dzib JF, Fischer E, Amar L, Mulatero P, Samson-Couterie B, Hahner S, Quinkler M, Fallo F, Letizia C, Allolio B, Ceolotto G, Cicala MV, Lang K, Lefebvre H, Lenzini L, Maniero C, Monticone S, Perrocheau M, Pilon C, Plouin PF, Rayes N, Seccia TM, Veglio F, Williams TA, Zinnamosca L, Mantero F, Benecke A, Jeunemaitre X, Reincke M, Zennaro MC.

Hypertension. 2012 Mar;59(3):592-8. doi: 10.1161/HYPERTENSIONAHA.111.186478. Epub 2012 Jan 23.

PMID:
22275527
[PubMed - indexed for MEDLINE]
Free Article
8.

New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.

Scholl UI, Lifton RP.

Curr Opin Nephrol Hypertens. 2013 Mar;22(2):141-7. doi: 10.1097/MNH.0b013e32835cecf8. Review.

PMID:
23318698
[PubMed - indexed for MEDLINE]
9.

a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.

Monticone S, Hattangady NG, Penton D, Isales CM, Edwards MA, Williams TA, Sterner C, Warth R, Mulatero P, Rainey WE.

J Clin Endocrinol Metab. 2013 Nov;98(11):E1861-5. doi: 10.1210/jc.2013-2428. Epub 2013 Sep 13.

PMID:
24037882
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.

Fernandes-Rosa FL, Williams TA, Riester A, Steichen O, Beuschlein F, Boulkroun S, Strom TM, Monticone S, Amar L, Meatchi T, Mantero F, Cicala MV, Quinkler M, Fallo F, Allolio B, Bernini G, Maccario M, Giacchetti G, Jeunemaitre X, Mulatero P, Reincke M, Zennaro MC.

Hypertension. 2014 Aug;64(2):354-61. doi: 10.1161/HYPERTENSIONAHA.114.03419. Epub 2014 May 27.

PMID:
24866132
[PubMed - indexed for MEDLINE]
11.

Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.

Williams TA, Monticone S, Schack VR, Stindl J, Burrello J, Buffolo F, Annaratone L, Castellano I, Beuschlein F, Reincke M, Lucatello B, Ronconi V, Fallo F, Bernini G, Maccario M, Giacchetti G, Veglio F, Warth R, Vilsen B, Mulatero P.

Hypertension. 2014 Jan;63(1):188-95. doi: 10.1161/HYPERTENSIONAHA.113.01733. Epub 2013 Sep 30.

PMID:
24082052
[PubMed - indexed for MEDLINE]
Free Article
12.

Novel genes in primary aldosteronism.

Fischer E, Beuschlein F.

Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):154-8. doi: 10.1097/MED.0000000000000060. Review.

PMID:
24739312
[PubMed - indexed for MEDLINE]
13.

Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.

Oki K, Plonczynski MW, Luis Lam M, Gomez-Sanchez EP, Gomez-Sanchez CE.

Endocrinology. 2012 Apr;153(4):1774-82. doi: 10.1210/en.2011-1733. Epub 2012 Feb 7.

PMID:
22315453
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway.

Arnesen T, Glomnes N, Strømsøy S, Knappskog S, Heie A, Akslen LA, Grytaas M, Varhaug JE, Gimm O, Brauckhoff M.

Langenbecks Arch Surg. 2013 Aug;398(6):869-74. doi: 10.1007/s00423-013-1093-2. Epub 2013 Jun 19.

PMID:
23778974
[PubMed - indexed for MEDLINE]
15.

A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.

Kuppusamy M, Caroccia B, Stindl J, Bandulik S, Lenzini L, Gioco F, Fishman V, Zanotti G, Gomez-Sanchez C, Bader M, Warth R, Rossi GP.

J Clin Endocrinol Metab. 2014 Sep;99(9):E1765-73. doi: 10.1210/jc.2014-1927. Epub 2014 Jul 24.

PMID:
25057880
[PubMed - indexed for MEDLINE]
16.

Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.

Monticone S, Hattangady NG, Nishimoto K, Mantero F, Rubin B, Cicala MV, Pezzani R, Auchus RJ, Ghayee HK, Shibata H, Kurihara I, Williams TA, Giri JG, Bollag RJ, Edwards MA, Isales CM, Rainey WE.

J Clin Endocrinol Metab. 2012 Aug;97(8):E1567-72. doi: 10.1210/jc.2011-3132. Epub 2012 May 24.

PMID:
22628608
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Genetic variations in the KCNJ5 gene in primary aldosteronism patients from Xinjiang, China.

Li NF, Li HJ, Zhang DL, Zhang JH, Yao XG, Wang HM, Abulikemu S, Zhou KM, Zhang XY.

PLoS One. 2013;8(1):e54051. doi: 10.1371/journal.pone.0054051. Epub 2013 Jan 31.

PMID:
23382865
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.

Seccia TM, Mantero F, Letizia C, Kuppusamy M, Caroccia B, Barisa M, Cicala MV, Miotto D, Rossi GP.

J Clin Endocrinol Metab. 2012 Dec;97(12):E2307-13. doi: 10.1210/jc.2012-2342. Epub 2012 Sep 25.

PMID:
23012392
[PubMed - indexed for MEDLINE]
19.

New genetic insights in familial hyperaldosteronism.

Jackson RV, Lafferty A, Torpy DJ, Stratakis C.

Ann N Y Acad Sci. 2002 Sep;970:77-88. Review.

PMID:
12381543
[PubMed - indexed for MEDLINE]
20.

Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.

Scholl UI, Nelson-Williams C, Yue P, Grekin R, Wyatt RJ, Dillon MJ, Couch R, Hammer LK, Harley FL, Farhi A, Wang WH, Lifton RP.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2533-8. doi: 10.1073/pnas.1121407109. Epub 2012 Jan 30.

PMID:
22308486
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk